Taiho Pharmaceutical Company Limited

Ishikawajima-Harima Jukogyo Kabushiki Kaisha

Hamamatsu Tv Co, Ltd.

Medical Proteoscope Co., Ltd.

Harubumi Kato

Yutaka Tsuchiya

Takashi Hirano

Hiromi Wada

Teruo Hiruma

Hiroyuki Shiozaki

Junichi Maeda

Katsuo Aizawa

Sadao Degawa

Takeyasu Amano

Takeshi Udagawa

Tooru Hirano

Keiji Kainuma

Takao Kawakami

Yousuke Fukui

Yukito Ichinose

Atsushi Honma

Yoshihiro Hayata

Mitsuo Ohta

Atsushi Ogiwara

Masahiro Tsuboi

Shingo Akimoto

Mikio Mori

The present invention relates to a method for predicting the postoperative prognosis of a lung adenocarcinoma patient with high sensitivity and/or specificity by identifying a protein with an expression level that specifically varies in a lung adenocarcinoma patient, comprising: step (a) of determining expression levels of myosin IIA and/or vimentin in a biological sample collected from a lung adenocarcinoma patient; and step (b) of predicting or determining a prognosis based on the expression levels of myosin IIA and/or vimentin obtained as a result of determination.

Method for prediction of postoperative prognosis and diagnosis kit

The present invention provides an improved method for treating lung cancer, preferably non-small cell lung cancer, by orally administering UFT to postoperative lung cancer patients.

Postoperative adjuvant chemotherapy with UFT

In a solid-state laser, a YAG laser generates laser beam with a predetermined wavelength in response to which a titanium-sapphire laser is pumped to generate laser beam with a predetermined wavelength which is administered through a fiberscope to irradiate focuses, treating or destroying the same.

Cancer therapy system

Cancer diagnosis device contains an endoscope comprising a light pipe used to transmit light beams from respective light sources and an image guide used to observe the flesh of the organism during both diagnosis and treatment. The tip of the endoscope faces toward the focuses where a photosensitive material having an affinity to the focuses of cancer has been absorbed so that a treatment for cancer can be performed by exposing the organism affected by cancer to the laser beam. The attainable the laser beam within a focus is thus increased by the use of the laser beam pulse from a first laser beam pulse source. In addition to the above, the cancer diagnosis device contains a second laser beam pulse source used to transmit a light beam to the focuses through the light pipe for making a diagnosis, a selector used to selectively pick up the light beam from the first laser beam pulse source or the second laser beam pulse source, a spectroscope used to obtain the spectral response from emission of light led through the image guide used for observation from the flesh of the organism where fluorescence occurs, an imaging device used to pick up the spectral response, a graphic display used to graphically display the processed spectra picked up by the imaging device, and a controller used to control emission of light from the second laser beam pulse source and also to make the operation of the imaging device synchronize with the second laser beam pulse source.

Cancer diagnosis device utilizing laser beam pulses

Growing community of inventors

Tokyo, Japan

Harubumi Kato